tirzepatide surmount-1 weight loss percent 72 weeks Treatment Leads to of up to 22.5% in Clinical Trial Lilly's triple agonist delivers up

Treatment Protocol Research Limitations Moderate sample size (n=45)

Ding, X

Eating slowly and avoiding carbonated beverages can reduce this

also approved for chronic weight management in adults (refer to current MHRA and NICE Technology Appraisal guidance for the applicable indication and eligibility criteria) [4] [7] Orlistat available on NHS prescription and over the counter Naltrexone/bupropion (Mysimba) available in some settings, though NHS commissioning varies by region [10] NICE Technology Appraisals provide eligibility criteria and commissioning guidance for semaglutide and tirzepatide in weight management

3 or Red No

Vrang N, Jelsing J, Simonsen L, Jensen AE, Thorup I, Soeborg H, and Knudsen LB